Gina Rizzo
Obstetrics & Gynecology · Baytown, TXNPI 1508183534
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $645 and has fallen 86.7% since, to $86 in 2023.
Across 83 payments — averaging $23.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$457
- Davol Inc.$219
- Bayer$161
- Mayne Pharma Commercial LLC$130
- Pacira Pharmaceuticals Incorporated$124
- Hologic Sales And Service, LLC$104
- plus $748 from 20 others
What the payments were for
- Food & beverage$1,88097%
- Education$643%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $457 |
| Davol Inc. | 2 | $219 |
| Bayer | 8 | $161 |
| Mayne Pharma Commercial LLC | 5 | $130 |
| Pacira Pharmaceuticals Incorporated | 1 | $124 |
| Hologic Sales And Service, LLC | 6 | $104 |
| Lupin Inc. | 5 | $91 |
| Myovant Sciences Inc. | 5 | $90 |
| Astellas Pharma US Inc | 4 | $69 |
| Organon | 3 | $63 |
| Avanos Medical | 1 | $49 |
| AMAG Pharmaceuticals, Inc. | 3 | $47 |
| Aspira Women's Health Inc | 2 | $47 |
| Merck | 3 | $42 |
| Covidien LP | 2 | $30 |
| Scynexis, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $23 |
| Medtronic | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Shield Therapeutics Inc | 1 | $15 |
| Millicent US Inc | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTA AH FLEXITIP$162
- EXPAREL$124
- Orilissa$100
How this compares
$1,944 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $454 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Baytown
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.